ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET
Company Participants
Skyler Bloom - Senior Director of Business Development & Corporate Strategy
Adam Grossman - Co-Founder, President, CEO & Director
Brian Lenz - EVP, CFO & GM, ADMA BioCenters
Conference Call Participants
Anthony Petrone - Mizuho Securities
Elliot Wilbur - Raymond James & Associates
Kristen Kluska - Cantor Fitzgerald & Co.
Operator
Good afternoon, and welcome to the ADMA Biologics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call on Thursday, March 23, 2023. [Operator Instructions]. Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately two hours following the end of the call.
At this time, I would like to introduce Skyler Bloom, Senior Director, Business Development and Corporate Strategy at ADMA Biologics. Please go ahead.
Skyler Bloom
Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics' financial results for the fourth quarter and full year 2022 and recent corporate updates. I'm joined today by Adam Grossman, President and Chief Executive Officer; and Brian Lenz, Executive Vice President, Chief Financial Officer and General Manager of ADMA BioCenters.
During today's call, Adam will provide some introductory comments and provide an update on corporate progress, and then Brian will provide an overview of the company's fourth quarter 2022 financial results. Finally, Adam will then provide some brief summary remarks before opening the call up for your questions.
Earlier today, we issued a press release detailing the fourth quarter and full year 2022 financial results and summarizing certain achievements in recent corporate updates. The release is available on our website at www.admabiologics.com.
Before we begin our formal comments, I'll remind you that we will be making forward-looking assertions during today's call that represent the company's intentions, expectations or beliefs concerning future events, which constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to factors, risks and uncertainties such as those detailed in today's press release announcing this call and in our filings with the SEC, which may cause actual results to differ materially from the results expressed or implied by such statements. In addition, any forward-looking statements represent our views only as of the date of this call and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update any such statements, except as required by the federal securities laws.